Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies - PubMed (original) (raw)
Review
Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies
M Huss et al. J Atten Disord. 2002.
Abstract
This article reviews pharmacological, animal, and human evidence regarding the abuse liability of methylphenidate (MPH). Findings are not always consistent, but evidence converges to suggest that although intravenous methylphenidate has some abuse potential, there is very little potential for oral MPH abuse. Furthermore, the available data suggests that children with Attention-Deficit/Hyperactivity Disorder (ADHD) who are treated with MPH are at lower risk for substance use disorder later in life. More longitudinal, prospective studies are needed to assess the long term effects of MPH treatment in ADHD.
Similar articles
- Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
Quinn D, Wigal S, Swanson J, Hirsch S, Ottolini Y, Dariani M, Roffman M, Zeldis J, Cooper T. Quinn D, et al. J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1422-9. doi: 10.1097/01.chi.0000140455.96946.2b. J Am Acad Child Adolesc Psychiatry. 2004. PMID: 15502602 Clinical Trial. - An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations.
Shellenberg TP, Stoops WW, Lile JA, Rush CR. Shellenberg TP, et al. Expert Rev Clin Pharmacol. 2020 Aug;13(8):825-833. doi: 10.1080/17512433.2020.1796636. Epub 2020 Jul 25. Expert Rev Clin Pharmacol. 2020. PMID: 32715789 Review. - Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder.
Becker SP, Froehlich TE, Epstein JN. Becker SP, et al. J Dev Behav Pediatr. 2016 Jun;37(5):395-404. doi: 10.1097/DBP.0000000000000285. J Dev Behav Pediatr. 2016. PMID: 27011002 Free PMC article. - Effect of methylphenidate on motivation in children with attention-deficit/hyperactivity disorder.
Chelonis JJ, Johnson TA, Ferguson SA, Berry KJ, Kubacak B, Edwards MC, Paule MG. Chelonis JJ, et al. Exp Clin Psychopharmacol. 2011 Apr;19(2):145-53. doi: 10.1037/a0022794. Exp Clin Psychopharmacol. 2011. PMID: 21463072 - Cognitive and emotional behavioural changes associated with methylphenidate treatment: a review of preclinical studies.
Britton GB. Britton GB. Int J Neuropsychopharmacol. 2012 Feb;15(1):41-53. doi: 10.1017/S1461145711000472. Epub 2011 Mar 25. Int J Neuropsychopharmacol. 2012. PMID: 21439107 Review.
Cited by
- The effect of ADHD on the life of an individual, their family, and community from preschool to adult life.
Harpin VA. Harpin VA. Arch Dis Child. 2005 Feb;90 Suppl 1(Suppl 1):i2-7. doi: 10.1136/adc.2004.059006. Arch Dis Child. 2005. PMID: 15665153 Free PMC article. Review. - Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
Schubiner H. Schubiner H. CNS Drugs. 2005;19(8):643-55. doi: 10.2165/00023210-200519080-00001. CNS Drugs. 2005. PMID: 16097847 Review. - Influence of methylphenidate on brain development--an update of recent animal experiments.
Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert-Noodt G. Grund T, et al. Behav Brain Funct. 2006 Jan 10;2:2. doi: 10.1186/1744-9081-2-2. Behav Brain Funct. 2006. PMID: 16403217 Free PMC article. - Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J. Wilens TE, et al. Arch Pediatr Adolesc Med. 2008 Oct;162(10):916-21. doi: 10.1001/archpedi.162.10.916. Arch Pediatr Adolesc Med. 2008. PMID: 18838643 Free PMC article. - Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.
Huang YS, Tsai MH. Huang YS, et al. CNS Drugs. 2011 Jul;25(7):539-54. doi: 10.2165/11589380-000000000-00000. CNS Drugs. 2011. PMID: 21699268 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical